Search Results - Martin Richardet

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden by Alexandra Leary, Paolo A Ascierto, Michele Maio, Georgia Kollia, Jennifer Friedmann, Marina Tschaika, Patrick Schöffski, Jonathan Baden, Neeltje Steeghs, Parul Doshi, Massimo Di Nicola, Jean-Pierre Delord, Iwona Lugowska, Mauricio Burotto, David S P Tan, Anthony Gonçalves, Michael Schenker, Ning Huang, Tudor-Eliade Ciuleanu, Martin Richardet, Lorena Lupinacci, Julieta Grasselli, Jacqueline Vuky, Somasekhar Konduru, Sai Vikram Vemula, Ruta Slepetis, Misena Pacius, Quyen Duong

    Published in Journal for ImmunoTherapy of Cancer (2024-08-01)
    Get full text
    Article


  2. 2

    Treatment Trends in Metastatic Renal Clear Cell Carcinoma in Argentina by Federico Cayol, Gabriela Gatica, Pablo Companys, Carolina Passarella, Rodrigo Sanchez, Ernesto Korbenfeld, Jose Zarba, Omar Carranza, Ruben Kowalyszyn, Gonzalo Taetti, Martín Richardet, Ezequiel Espamer, Mauricio Fernandez Lazaro, Laura Pelagatti, Nicolas Mainardi, Matías Cortes, José Peñaloza, Hernan Cutuli, María Pía Dominguez, Harold Somerville, Florencia Sarru, Juan Pablo Sade, Augusto Ferreyra Camacho, Emiliano Menna, Ivan Macharashvili, Rosalía Hinojosa Altamirano, Andrea Marchioni, Federico Losco, Pamela López, Tomas Soule, Mariano Aymar, Ignacio Jerez, Juan Ignacio Hernández Morán, María Natalia Gandur Quiroga, Martín Angel

    Published in JCO Global Oncology (2025-04-01)
    Get full text
    Article


Search Tools: